Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects

Diabetic Medicine

Volumn 13, Issue 7, 1996, Pages 634-641

  Peacey, S R ^a   George, E ^a   Rostami Hodjegan, A ^b   Bedford, C ^a   Harris, N ^b   Hardisty, C A ^a   Tucker, G T ^b   Macdonald, I A ^c   Heller, S R ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cognitive function; Counterregulation; Hypoglycaemia; Hypoglycaemia awareness; Insulin; Sulphonylurea; Tolbutamide

Indexed keywords

HUMAN INSULIN; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ADULT; ARTICLE; COGNITION; FEMALE; HUMAN; HYPOGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HEMODYNAMIC PROCESSES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; REACTION TIME; RECOMBINANT PROTEINS; SWEATING; TOLBUTAMIDE; TREMOR;

EID: 0030055514     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199607)13:7<634::AID-DIA136>3.0.CO;2-Z     Document Type: Article

References (33)

1. Jennings AM, Wilson RM, Ward JD. Symptomatic hypoglycaemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 1989; 12: 203-208.
2. Fox C, Cull CA, Holman RR. Three year response to randomly allocated therapy with diet, sulphonylurea or insulin in 1592 diabetic patients (Abstract). Diabetic Med 1991; 8 (suppl 1): 8A.
3. Dahlen M, Bergman U, Idman L, Martinsson L, Karlsson G. Epidemiology of hypoglycaemia in patients on oral antidiabetic drugs in the island of Gotland, Sweden. Acta Endocrinol 1984; 263 (suppl 1): 21.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
5. Jackson WPU, Van Mieghem W, Keller P. Observations of the mechanisms of action of the sulfonylureas under clinical conditions. Metab Clin Exp 1973; 22: 1155-1162.
6. Liu D, Moberg E, Kollind M, Lins PE, Adamsson U. A high concentration of circulating insulin suppresses the glucagon response to hypoglycaemia in normal man. J Clin Endocrinol Metab 1991; 73: 1123-1128.
7. Diamond MP, Hallerman L, Starick-Zych K, Jones TW, Connolly-Howard M, Tamborlane WV, et al. Suppression of counterregulatory hormone response to hypoglycaemia by insulin per se. J Clin Endocrinol Metab 1991; 72: 1388-1390.
8. Davis SN, Goldstein RE, Jacobs J, Price L, Wolfe R, Cherrington AD. The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycaemia in normal humans. Diabetes 1993, 42: 263-272.
9. Marchetti P, Navalesi R. Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents: an update. Clin Pharmacokin 1989, 16: 100-128.
10. Lewis GF, Steiner G, Polonsky KS, Weller B, Zinman B. A new method for comparing portal and peripheral venous insulin delivery in humans: Tolbutamide vs insulin infusion. J Clin Endocrinol Metab 1994; 78: 66-70.
11. Liu D, Moberg E, Kollind M, Lins P-E, Adamson U. Arterial, arterialised venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992; 35: 287-290.
12. Ganda OP, Khan CB, Soeldner JS, Gleason RE. Dynamics of tolbutamide, glucose and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects. Diabetes 1975; 24: 354-361.
13. Bohannon NV, Lorenzi M, Grodsky GM, Karam JH. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects. J Clin Endocrinol Metab 1982; 54: 459-462.
14. Forster CD, Taylor JY, Macdonald IA. The assay of the catecholamine content of small volumes of human plasma. In: Rollema H, Westerink BHC, Drijfhout WJ, eds. Monitoring Molecules in Neuroscience. Groningen: University Centre for Pharmacy, 1991: 173-175.
15. Stout RW, Henry RW, Buchanan KD. Triglyceride metabolism in acute starvation: the role of secretin and glucagon. Eur J Clin Invest 1976; 6: 179-185.
16. Heding LG. Radioimmunological determinations of human C-peptide in serum. Diabetologia 1975; 11: 541-554.
17. Soeldner JS, Sloane D. Critical variables in the RIA of serum insulin using the double antibody system. Diabetes 1965; 14: 771-779.
18. Nation RL, Peng GW, Chio WL. Simple rapid and micro high-pressure liquid Chromatographic method for the simultaneous determination of tolbutamide and carboxytolbutamide in plasma. J Chromatog 1978; 146: 126-131.
19. Smallwood RH, Thomas SE. An inexpensive portable monitor for measuring evaporative water loss. Clin Phys Physiol Meas 1985; 6: 147-154.
20. George E, Harris N, Bedford C, Macdonald IA, Hardisty CA, Heller SR. Prolonged but partial impairment of the hypoglycaemic physiological response following short term hypoglycaemia in normal subjects. Diabetologia 1995; 38: 1183-1190.
21. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 1993; 36: 771-777.
22. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behaviour. J Clin Endocrinol Metab 1980; 51: 520-528.
23. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue R, Galloway J, et al. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and Type 1 diabetic patients. J Clin Invest 1986; 77: 98-105.
24. DeFronzo RE, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of the splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983; 32: 35-45.
25. DeFeo P, Perriello C, DeCosmo S, Ventura MM, Campbell PJ, Brunetti P, et al. Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 1986, 35: 563-569.
26. Liu D, Adamson UCK, Lins PES, Kollind ME, Moberg EAR, Andreasson K. Inhibitory effect of circulating insulin on glucagon secretion during hypoglycaemia in Type I diabetic patients. Diabetes Care 1992; 15: 59-65.
27. Kerr D, Reza M, Smith N, Leatherdale BA. Importance of insulin in subjective, cognitive and hormonal responses to hypoglycemia in patients with IDDM. Diabetes 1991; 40: 1057-1062.
28. Mellman MJ, Davis MR, Shamoon H. Effect of physiological hyperinsulinemia on counterregulatory hormone responses during hypoglycemia in humans. J Clin Endocrinol Metab 1992; 75: 1293-1297.
29. McCulloch DK, Raghu PK, Koerker DJ, Palmer JP, Klaff LJ. Responses of the pancreatic A cell during hypoglycemia and hyperglycemia are dependent on the B cell. Metabolism 1989; 38: 702-707.
30. Bolli G, De Feo P, Perriello G, De Cosmo S, Compagnucci P, Santeusanio F, et al. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man: role of the beta cell and arterial hyperinsulinemia. J Clin Invest 1984; 73: 917-922.
31. Kerr D, Tamborlane WV, Rife F, Sherwin RS. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. J Clin Invest 1993; 91: 141-147.
32. Hepburn DA, MacLeod KM, Pell ACH, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with Type 2 diabetes treated with insulin. Diabetic Med 1992; 10: 231-237.
33. + channels. Science 1990; 247: 852-854.